Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 359

1.

The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia.

Keck PE Jr, Strakowski SM, McElroy SL.

J Clin Psychiatry. 2000;61 Suppl 3:4-9. Review.

PMID:
10724127
[PubMed - indexed for MEDLINE]
2.

Atypical antipsychotics for treatment of depression in schizophrenia and affective disorders. Collaborative Working Group on Clinical Trial Evaluations.

[No authors listed]

J Clin Psychiatry. 1998;59 Suppl 12:41-5. Review.

PMID:
9766619
[PubMed - indexed for MEDLINE]
3.

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.

McEvoy JP, Lieberman JA, Stroup TS, Davis SM, Meltzer HY, Rosenheck RA, Swartz MS, Perkins DO, Keefe RS, Davis CE, Severe J, Hsiao JK; CATIE Investigators.

Am J Psychiatry. 2006 Apr;163(4):600-10.

PMID:
16585434
[PubMed - indexed for MEDLINE]
4.

Use of atypical antipsychotics in mood disorders.

Weizman R, Weizman A.

Curr Opin Investig Drugs. 2001 Jul;2(7):940-5. Review.

PMID:
11757795
[PubMed - indexed for MEDLINE]
5.

Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia.

Weiden PJ, Simpson GM, Potkin SG, O'Sullivan RL.

J Clin Psychiatry. 2003 May;64(5):580-8.

PMID:
12755663
[PubMed - indexed for MEDLINE]
6.

[Atypical neuroleptics in the treatment of aggression and hostility in schizophrenic patients].

Briken P, Nika E, Krausz M, Naber D.

Fortschr Neurol Psychiatr. 2002 Mar;70(3):139-44. Review. German.

PMID:
11880946
[PubMed - indexed for MEDLINE]
7.

Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.

Atmaca M, Kuloglu M, Tezcan E, Ustundag B.

J Clin Psychiatry. 2003 May;64(5):598-604.

PMID:
12755665
[PubMed - indexed for MEDLINE]
8.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
9.

Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.

Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M.

J Clin Psychiatry. 2004 Apr;65(4):551-6.

PMID:
15119920
[PubMed - indexed for MEDLINE]
11.

Atypical antipsychotic drugs and long-term outcome in schizophrenia.

Weiden P, Aquila R, Standard J.

J Clin Psychiatry. 1996;57 Suppl 11:53-60. Review.

PMID:
8941171
[PubMed - indexed for MEDLINE]
12.

Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.

Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.

Am J Psychiatry. 2002 Feb;159(2):255-62. Erratum in: Am J Psychiatry 2002 Dec;159(12):2132.

PMID:
11823268
[PubMed - indexed for MEDLINE]
13.

Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.

Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Rosenheck RA, Perkins DO, Keefe RS, Davis CE, Severe J, Hsiao JK; CATIE Investigators.

Am J Psychiatry. 2006 Apr;163(4):611-22.

PMID:
16585435
[PubMed - indexed for MEDLINE]
14.

Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia.

Kinon BJ, Liu-Seifert H, Adams DH, Citrome L.

J Clin Psychopharmacol. 2006 Dec;26(6):632-7.

PMID:
17110821
[PubMed - indexed for MEDLINE]
15.

Treatment refractory schizophrenia: how should we proceed?

Sharif ZA.

Psychiatr Q. 1998 Winter;69(4):263-81. Review.

PMID:
9793107
[PubMed - indexed for MEDLINE]
16.

Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.

Citrome L, Volavka J, Czobor P, Sheitman B, Lindenmayer JP, McEvoy J, Cooper TB, Chakos M, Lieberman JA.

Psychiatr Serv. 2001 Nov;52(11):1510-4.

PMID:
11684748
[PubMed - indexed for MEDLINE]
17.

The value of atypical antipsychotics in the treatment of schizophrenia.

Jessen LM.

Manag Care. 2002 Jul;11(7 Suppl):8-12; discussion 12-3. No abstract available.

PMID:
12181875
[PubMed - indexed for MEDLINE]
Free Article
18.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
19.

Ziprasidone: a new atypical antipsychotic.

Keck PE Jr, McElroy SL, Arnold LM.

Expert Opin Pharmacother. 2001 Jun;2(6):1033-42. Review.

PMID:
11585006
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk